# The Correlation of Computed Tomography (CT)-Based Body Composition and Survival in Pancreatic Cancer Patients: A Systematic Review

## TL;DR

This review shows that body composition measured via CT scans can predict survival in pancreatic cancer patients better than BMI.

## Contribution

The study systematically reviews the link between CT-based body composition and survival in pancreatic cancer.

## Key findings

- 21 out of 23 studies found a significant correlation between body composition and survival.
- Changes in body composition during treatment were more predictive than baseline measurements.
- Visceral fat is linked to worse outcomes, while subcutaneous fat and muscle density are associated with better survival.

## Abstract

In pancreatic cancer, the amount and distribution of muscle and fat can influence how well the patient does after surgery and during treatment. Standard measures like body mass index do not reliably predict survival, whereas detailed assessments of body composition using CT scans may provide more accurate prognostic information. Patients with higher levels of visceral fat (fat around abdominal organs) tend to have a higher risk of early cancer recurrence and shorter overall survival, while those with more subcutaneous fat (fat under the skin) and greater muscle density generally have better survival outcomes.

Background/Objectives: Pancreatic cancer is among the most aggressive malignancies, with poor survival rates. Emerging evidence suggests that body composition, including skeletal muscle mass and adiposity distribution, plays a crucial role in predicting patient outcomes. However, its impact on survival in pancreatic cancer remains incompletely understood. The aim of this systematic review was to assess the correlation between body composition parameters and survival outcomes in pancreatic cancer patients, focusing on overall survival. Methods: A comprehensive literature search was conducted, including three main components: pancreatic cancer, body composition, and survival outcomes. Results: 23 studies were included in this review. The findings indicate that body composition can serve as a predictor of survival in pancreatic cancer patients, with 21 studies reporting a significant correlation. The most frequently observed predictor, with 11 studies reporting, was not a baseline parameter but rather changes in parameters over time during treatment. However, discrepancies remain regarding the extent of predictive power and the relative importance of individual components. Conclusions: Specific body composition parameters hold potential as prognostic indicators of survival in pancreatic cancer patients. However, further research is necessary to establish consistent patterns and to clarify which parameters are most predictive and under what conditions.